The Rare Anaphylaxis-Associated FcγRIIa3 Exhibits Distinct Characteristics From the Canonical FcγRIIa1

FcγRIIa is an activating FcγR, unique to humans and non-human primates. It induces antibody-dependent proinflammatory responses and exists predominantly as FcγRIIa1. A unique splice variant, we designated FcγRIIa3, has been reported to be associated with anaphylactic reactions to intravenous immunog...

Full description

Bibliographic Details
Main Authors: Jessica C. Anania, Halina M. Trist, Catherine S. Palmer, Peck Szee Tan, Betty P. Kouskousis, Alicia M. Chenoweth, Stephen J. Kent, Graham A. Mackay, Alberta Hoi, Rachel Koelmeyer, Charlotte Slade, Vanessa L. Bryant, Philip D. Hodgkin, Pei Mun Aui, Menno C. van Zelm, Bruce D. Wines, P. Mark Hogarth
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-08-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2018.01809/full
id doaj-8f1f72bd8c604a6cb933aa7bfdb9d2cc
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Jessica C. Anania
Jessica C. Anania
Halina M. Trist
Catherine S. Palmer
Catherine S. Palmer
Peck Szee Tan
Betty P. Kouskousis
Betty P. Kouskousis
Alicia M. Chenoweth
Alicia M. Chenoweth
Stephen J. Kent
Stephen J. Kent
Stephen J. Kent
Graham A. Mackay
Alberta Hoi
Rachel Koelmeyer
Charlotte Slade
Charlotte Slade
Charlotte Slade
Charlotte Slade
Vanessa L. Bryant
Vanessa L. Bryant
Vanessa L. Bryant
Vanessa L. Bryant
Philip D. Hodgkin
Philip D. Hodgkin
Pei Mun Aui
Pei Mun Aui
Menno C. van Zelm
Menno C. van Zelm
Bruce D. Wines
Bruce D. Wines
Bruce D. Wines
P. Mark Hogarth
P. Mark Hogarth
P. Mark Hogarth
spellingShingle Jessica C. Anania
Jessica C. Anania
Halina M. Trist
Catherine S. Palmer
Catherine S. Palmer
Peck Szee Tan
Betty P. Kouskousis
Betty P. Kouskousis
Alicia M. Chenoweth
Alicia M. Chenoweth
Stephen J. Kent
Stephen J. Kent
Stephen J. Kent
Graham A. Mackay
Alberta Hoi
Rachel Koelmeyer
Charlotte Slade
Charlotte Slade
Charlotte Slade
Charlotte Slade
Vanessa L. Bryant
Vanessa L. Bryant
Vanessa L. Bryant
Vanessa L. Bryant
Philip D. Hodgkin
Philip D. Hodgkin
Pei Mun Aui
Pei Mun Aui
Menno C. van Zelm
Menno C. van Zelm
Bruce D. Wines
Bruce D. Wines
Bruce D. Wines
P. Mark Hogarth
P. Mark Hogarth
P. Mark Hogarth
The Rare Anaphylaxis-Associated FcγRIIa3 Exhibits Distinct Characteristics From the Canonical FcγRIIa1
Frontiers in Immunology
Fc receptors
common variable immunodeficiency
immunodeficiency
systemic lupus erythematosus
immune complex
non-human primates
author_facet Jessica C. Anania
Jessica C. Anania
Halina M. Trist
Catherine S. Palmer
Catherine S. Palmer
Peck Szee Tan
Betty P. Kouskousis
Betty P. Kouskousis
Alicia M. Chenoweth
Alicia M. Chenoweth
Stephen J. Kent
Stephen J. Kent
Stephen J. Kent
Graham A. Mackay
Alberta Hoi
Rachel Koelmeyer
Charlotte Slade
Charlotte Slade
Charlotte Slade
Charlotte Slade
Vanessa L. Bryant
Vanessa L. Bryant
Vanessa L. Bryant
Vanessa L. Bryant
Philip D. Hodgkin
Philip D. Hodgkin
Pei Mun Aui
Pei Mun Aui
Menno C. van Zelm
Menno C. van Zelm
Bruce D. Wines
Bruce D. Wines
Bruce D. Wines
P. Mark Hogarth
P. Mark Hogarth
P. Mark Hogarth
author_sort Jessica C. Anania
title The Rare Anaphylaxis-Associated FcγRIIa3 Exhibits Distinct Characteristics From the Canonical FcγRIIa1
title_short The Rare Anaphylaxis-Associated FcγRIIa3 Exhibits Distinct Characteristics From the Canonical FcγRIIa1
title_full The Rare Anaphylaxis-Associated FcγRIIa3 Exhibits Distinct Characteristics From the Canonical FcγRIIa1
title_fullStr The Rare Anaphylaxis-Associated FcγRIIa3 Exhibits Distinct Characteristics From the Canonical FcγRIIa1
title_full_unstemmed The Rare Anaphylaxis-Associated FcγRIIa3 Exhibits Distinct Characteristics From the Canonical FcγRIIa1
title_sort rare anaphylaxis-associated fcγriia3 exhibits distinct characteristics from the canonical fcγriia1
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2018-08-01
description FcγRIIa is an activating FcγR, unique to humans and non-human primates. It induces antibody-dependent proinflammatory responses and exists predominantly as FcγRIIa1. A unique splice variant, we designated FcγRIIa3, has been reported to be associated with anaphylactic reactions to intravenous immunoglobulins (IVIg) therapy. We aim to define the functional consequences of this FcγRIIa variant associated with adverse responses to IVIg therapy and evaluate the frequency of associated SNPs. FcγRIIa forms from macaque and human PBMCs were investigated for IgG-subclass specificity, biochemistry, membrane localization, and functional activity. Disease-associated SNPs were analyzed by sequencing genomic DNA from 224 individuals with immunodeficiency or autoimmune disease. FcγRIIa3 was identified in macaque and human PBMC. The FcγRIIa3 is distinguished from the canonical FcγRIIa1 by a unique 19-amino acid cytoplasmic insertion and these two FcγRIIa forms responded distinctly to antibody ligation. Whereas FcγRIIa1 was rapidly internalized, FcγRIIa3 was retained longer at the membrane, inducing greater calcium mobilization and cell degranulation. Four FCGR2A SNPs were identified including the previously reported intronic SNP associated with anaphylaxis, but in only 1 of 224 individuals. The unique cytoplasmic element of FcγRIIa3 delays internalization and is associated with enhanced cellular activation. The frequency of the immunodeficiency-associated SNP varies between disease populations but interestingly occurred at a lower frequency than previously reported. None-the-less enhanced FcγRIIa3 function may promote a proinflammatory environment and predispose to pathological inflammatory responses.
topic Fc receptors
common variable immunodeficiency
immunodeficiency
systemic lupus erythematosus
immune complex
non-human primates
url https://www.frontiersin.org/article/10.3389/fimmu.2018.01809/full
work_keys_str_mv AT jessicacanania therareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT jessicacanania therareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT halinamtrist therareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT catherinespalmer therareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT catherinespalmer therareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT peckszeetan therareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT bettypkouskousis therareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT bettypkouskousis therareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT aliciamchenoweth therareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT aliciamchenoweth therareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT stephenjkent therareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT stephenjkent therareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT stephenjkent therareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT grahamamackay therareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT albertahoi therareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT rachelkoelmeyer therareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT charlotteslade therareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT charlotteslade therareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT charlotteslade therareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT charlotteslade therareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT vanessalbryant therareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT vanessalbryant therareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT vanessalbryant therareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT vanessalbryant therareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT philipdhodgkin therareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT philipdhodgkin therareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT peimunaui therareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT peimunaui therareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT mennocvanzelm therareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT mennocvanzelm therareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT brucedwines therareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT brucedwines therareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT brucedwines therareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT pmarkhogarth therareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT pmarkhogarth therareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT pmarkhogarth therareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT jessicacanania rareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT jessicacanania rareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT halinamtrist rareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT catherinespalmer rareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT catherinespalmer rareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT peckszeetan rareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT bettypkouskousis rareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT bettypkouskousis rareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT aliciamchenoweth rareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT aliciamchenoweth rareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT stephenjkent rareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT stephenjkent rareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT stephenjkent rareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT grahamamackay rareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT albertahoi rareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT rachelkoelmeyer rareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT charlotteslade rareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT charlotteslade rareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT charlotteslade rareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT charlotteslade rareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT vanessalbryant rareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT vanessalbryant rareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT vanessalbryant rareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT vanessalbryant rareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT philipdhodgkin rareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT philipdhodgkin rareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT peimunaui rareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT peimunaui rareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT mennocvanzelm rareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT mennocvanzelm rareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT brucedwines rareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT brucedwines rareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT brucedwines rareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT pmarkhogarth rareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT pmarkhogarth rareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
AT pmarkhogarth rareanaphylaxisassociatedfcgriia3exhibitsdistinctcharacteristicsfromthecanonicalfcgriia1
_version_ 1725957842561662976
spelling doaj-8f1f72bd8c604a6cb933aa7bfdb9d2cc2020-11-24T21:32:22ZengFrontiers Media S.A.Frontiers in Immunology1664-32242018-08-01910.3389/fimmu.2018.01809394759The Rare Anaphylaxis-Associated FcγRIIa3 Exhibits Distinct Characteristics From the Canonical FcγRIIa1Jessica C. Anania0Jessica C. Anania1Halina M. Trist2Catherine S. Palmer3Catherine S. Palmer4Peck Szee Tan5Betty P. Kouskousis6Betty P. Kouskousis7Alicia M. Chenoweth8Alicia M. Chenoweth9Stephen J. Kent10Stephen J. Kent11Stephen J. Kent12Graham A. Mackay13Alberta Hoi14Rachel Koelmeyer15Charlotte Slade16Charlotte Slade17Charlotte Slade18Charlotte Slade19Vanessa L. Bryant20Vanessa L. Bryant21Vanessa L. Bryant22Vanessa L. Bryant23Philip D. Hodgkin24Philip D. Hodgkin25Pei Mun Aui26Pei Mun Aui27Menno C. van Zelm28Menno C. van Zelm29Bruce D. Wines30Bruce D. Wines31Bruce D. Wines32P. Mark Hogarth33P. Mark Hogarth34P. Mark Hogarth35Immune Therapies Group, Burnet Institute, Melbourne, VIC, AustraliaDepartment of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, AustraliaImmune Therapies Group, Burnet Institute, Melbourne, VIC, AustraliaImmune Therapies Group, Burnet Institute, Melbourne, VIC, AustraliaMonash Micro Imaging, Monash University, Clayton, VIC, AustraliaImmune Therapies Group, Burnet Institute, Melbourne, VIC, AustraliaImmune Therapies Group, Burnet Institute, Melbourne, VIC, AustraliaMonash Micro Imaging, Monash University, Clayton, VIC, AustraliaImmune Therapies Group, Burnet Institute, Melbourne, VIC, AustraliaDepartment of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, AustraliaDepartment of Microbiology and Immunology, University of Melbourne, Parkville, VIC, AustraliaMelbourne Sexual Health Centre, Central Clinical School, Monash University, Melbourne, VIC, AustraliaARC Centre of Excellence in Convergent Bio-Nano Science and Technology, University of Melbourne, Parkville, VIC, AustraliaDepartment of Pharmacology & Therapeutics, The University of Melbourne, Parkville, VIC, AustraliaDepartment of Medicine, Monash Medical Centre, Clayton, VIC, AustraliaDepartment of Medicine, Monash Medical Centre, Clayton, VIC, AustraliaDepartment of Medical Biology, The University of Melbourne, Parkville, VIC, Australia0Walter and Eliza Hall Institute for Medical Research, Royal Melbourne Hospital, Parkville, VIC, Australia1Department of Clinical Immunology and Allergy, Royal Melbourne Hospital, Parkville, VIC, Australia2The Jeffrey Modell Diagnostic and Research Centre for Primary Immunodeficiencies, Melbourne, VIC, AustraliaDepartment of Medical Biology, The University of Melbourne, Parkville, VIC, Australia0Walter and Eliza Hall Institute for Medical Research, Royal Melbourne Hospital, Parkville, VIC, Australia1Department of Clinical Immunology and Allergy, Royal Melbourne Hospital, Parkville, VIC, Australia2The Jeffrey Modell Diagnostic and Research Centre for Primary Immunodeficiencies, Melbourne, VIC, AustraliaDepartment of Medical Biology, The University of Melbourne, Parkville, VIC, Australia0Walter and Eliza Hall Institute for Medical Research, Royal Melbourne Hospital, Parkville, VIC, AustraliaDepartment of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia2The Jeffrey Modell Diagnostic and Research Centre for Primary Immunodeficiencies, Melbourne, VIC, AustraliaDepartment of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia2The Jeffrey Modell Diagnostic and Research Centre for Primary Immunodeficiencies, Melbourne, VIC, AustraliaImmune Therapies Group, Burnet Institute, Melbourne, VIC, AustraliaDepartment of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia3Department of Pathology, The University of Melbourne, Parkville, VIC, AustraliaImmune Therapies Group, Burnet Institute, Melbourne, VIC, AustraliaDepartment of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia3Department of Pathology, The University of Melbourne, Parkville, VIC, AustraliaFcγRIIa is an activating FcγR, unique to humans and non-human primates. It induces antibody-dependent proinflammatory responses and exists predominantly as FcγRIIa1. A unique splice variant, we designated FcγRIIa3, has been reported to be associated with anaphylactic reactions to intravenous immunoglobulins (IVIg) therapy. We aim to define the functional consequences of this FcγRIIa variant associated with adverse responses to IVIg therapy and evaluate the frequency of associated SNPs. FcγRIIa forms from macaque and human PBMCs were investigated for IgG-subclass specificity, biochemistry, membrane localization, and functional activity. Disease-associated SNPs were analyzed by sequencing genomic DNA from 224 individuals with immunodeficiency or autoimmune disease. FcγRIIa3 was identified in macaque and human PBMC. The FcγRIIa3 is distinguished from the canonical FcγRIIa1 by a unique 19-amino acid cytoplasmic insertion and these two FcγRIIa forms responded distinctly to antibody ligation. Whereas FcγRIIa1 was rapidly internalized, FcγRIIa3 was retained longer at the membrane, inducing greater calcium mobilization and cell degranulation. Four FCGR2A SNPs were identified including the previously reported intronic SNP associated with anaphylaxis, but in only 1 of 224 individuals. The unique cytoplasmic element of FcγRIIa3 delays internalization and is associated with enhanced cellular activation. The frequency of the immunodeficiency-associated SNP varies between disease populations but interestingly occurred at a lower frequency than previously reported. None-the-less enhanced FcγRIIa3 function may promote a proinflammatory environment and predispose to pathological inflammatory responses.https://www.frontiersin.org/article/10.3389/fimmu.2018.01809/fullFc receptorscommon variable immunodeficiencyimmunodeficiencysystemic lupus erythematosusimmune complexnon-human primates